查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2143592

醫藥合約研發與生產服務市場：全球市場預測，2026-2032年

Pharmaceutical Customized R&D & Production Services Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，醫藥合約研發和生產服務市場將成長至 1,118.4 億美元，複合年成長率為 7.11%。

主要市場統計數據
基準年 2025 691.2億美元
預計年份：2026年 730.5億美元
預測年份 2032 1118.4億美元
複合年成長率 (%) 7.11%

客製化醫藥研發與生產服務：執行摘要

客製化的醫藥研發和生產服務透過外包研發、分析、臨床、法規、生產和供應鏈等職能，為醫藥開發公司提供支援。日益專業化的療法、更嚴格的品質要求、更短的研發週期以及在藥物發現、臨床開發和商業化供應的各個階段對靈活生產能力的需求，共同塑造了這一市場需求。該市場包含多種服務模式，使委託公司能夠利用技術專長和基礎設施，而無需自行建立所有職能。

專業化、柔軟性和合規性正在改變服務的提供方式。

行業趨勢正朝著整合和模組化的外包模式轉變。贊助商越來越重視能夠協調製程開發、分析測試、臨床樣本生產、技術轉移和法規文件的合作夥伴，同時又能柔軟性選擇合適的專家來完成複雜的任務。同時，先進療法、高活性化合物、無菌產品和個人化醫療的出現，也提高了對密閉性、驗證、冷鏈管理、數據完整性和品質源於設計 (QbD) 實踐的需求。此外，隨著企業供應商多元化、合格儲備產能以及提高對關鍵原料和整個生產過程的透明度，彈性採購變得日益重要。

人工智慧（AI）正在改善藥物發現、開發和生產流程。

人工智慧 (AI) 正透過化合物設計、標靶識別、實驗設計、流程最佳化、偏差分析、需求預測和文件審核等方式影響著客製化服務。其實際價值取決於經過檢驗的數據、可重現的工作流程、人工監督以及對模型管治和智慧財產權的明確控制。將 AI 與實驗室自動化、數位化品質系統和安全資料平台結合的服務供應商可以提升決策支援和營運應對力，但受監管的應用需要檢驗、網路安全、驗證以及對模型輸出的適當審查，而非未經驗證的自動化。

區域趨勢反映了它們各自的能力、法規和供應鏈優先事項。

在北美，生物技術活動蓬勃發展，臨床基礎設施完善，對專業研發和生產支援的需求強勁。在歐洲，重點在於品質系統、法規遵循、先進醫學專業知識和跨境合作。在亞太地區，我們看到技術能力不斷提升，先進製造流程日趨成熟，創新生態系統也在不斷發展，而贊助商仍重視品質穩定性和供應鏈韌性。在拉丁美洲，區域能力建設正在推進，重點在於可及性、在地化和夥伴關係。在中東，對生命科學基礎設施建設和多元化的投資不斷增加，而在非洲，與在地化生產、臨床研究、公共衛生重點和能力建設相關的機會正在湧現。

國際集團正在影響合作、監管和韌性。

東協在協調區域製造網路、跨境供應鏈以及技術和監管實踐方面發揮著至關重要的作用。金磚國家在科學、製造和病患群體方面擁有強大的實力，同時也努力克服監管體系和市場進入的差異。歐盟在其成熟的法律規範內，支持標準化和跨境發展的協調。七國集團成員國在尖端研究、品質標準和高度複雜的生產方面仍然具有影響力。海灣合作理事會成員國正透過投資和多元化努力加強其醫藥和生物技術基礎設施。北約成員國日益關注業務永續營運計畫、網路安全、關鍵材料和安全供應鏈，這些因素也對醫藥外包業務產生了影響。

每個國家的能力涵蓋創新領導力到能力建構等各個面向。

美國擁有廣泛的生物技術、臨床研究、監管和專業製造能力。加拿大在研究、臨床開發和跨境供應鏈網路方面表現卓越。巴西和墨西哥是拉丁美洲研發和生產生態系統的支柱，其發展機會受監管協調和當地市場進入優先事項的影響。英國、德國、法國、義大利和西班牙在相互關聯的歐洲體系內擁有成熟的研究、製造和品管基礎設施。中國和印度擁有廣泛的科學、分析和生產能力，而日本和韓國則以其先進的製造、精密技術和以品質為中心的研發而聞名。澳洲在研究、臨床和專業製造方面擁有豐富的專業知識。俄羅斯擁有科學和製造能力，但合作條件、合規要求和供應鏈准入因專案和司法管轄區而異。

產業領導者應建構穩健的、數據驅動的夥伴關係模式。

領導者在選擇合作夥伴之前，應根據模式、開發階段、風險和所需的技術控制對外包需求進行分類。此外，他們評估供應商資格時，不僅應考慮其生產能力，還應考慮其科學深度、品質記錄、檢驗準備、網路安全、資料完整性、業務永續營運和技術轉移能力。雙重來源和策略性選擇的備用方案可以降低關鍵材料和流程中斷的風險。經營團隊也應明確智慧財產權、數據、偏差、變更管理和監管申報的歸屬權。最後，組織應透過檢驗的用例、管治的資料管理實踐、可衡量的績效指標和持續的人工審核，選擇性地採用人工智慧。

調查方法：基於證據的服務、技術和本地訊號整合。

本執行摘要基於為製藥業量身定做的研發和生產服務範圍，從服務演進、技術應用、區域背景、國際格局和國家層面能力等方面對研究結果進行了梳理。研究結果整合了既定的產業結構、監管考量、營運模式以及製藥研發和生產領域的可觀察趨勢。本分析有意排除了市場估計和預測、市場佔有率、預測數據和公司排名。區域解讀反映了基礎設施、科學研究能力、政策、品質系統、供應鏈優先事項和在地化要求方面的差異。

策略展望：整合的專業技術和營運信任將決定競爭優勢。

製藥業的客製化研發和生產服務正變得日益專業化、互聯化和數據驅動。競爭優勢將越來越依賴科學專長、合規執行、靈活生產能力、安全資訊管理和穩健供應鏈網路的整合能力。將品質、透明度、技術管治和夥伴關係模式視為戰略能力的贊助商和服務供應商，將更有能力管理複雜的研發管線和應對不同地區不斷變化的監管預期。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：醫藥合約研發與生產服務市場：依服務類別分類

  • 綜合發展服務
    • Dmpk
    • 藥品法規合規性
    • 毒理學
  • 製造服務
    • API生產
    • 灌裝和精加工製造
    • 製藥生產
  • 研究與開發服務
    • 臨床開發
    • 藥物發現
    • 臨床前開發

第8章：醫藥合約研發與生產服務市場：依分子類別分類

  • 生物製劑
    • 單株抗體
    • 重組蛋白
    • 疫苗
  • 基因治療
    • 非病毒載體
    • 病毒載體
  • 胜肽和寡核苷酸
    • 寡核苷酸療法
    • 合成胜肽
  • 低分子

第9章：醫藥合約研發與生產服務市場：依治療領域分類

  • 心血管系統
    • 高血壓
    • 中風
  • 中樞神經系統
    • 阿茲海默症
    • 帕金森氏症
  • 感染疾病
    • 細菌感染疾病
    • 病毒感染疾病
  • 腫瘤學
    • 骨髓惡性腫瘤
    • 固體癌

第10章：醫藥合約研發與生產服務市場：依客戶類別分類

  • 學術機構
  • 生技公司
    • 一家歷史悠久的生物技術公司
    • 新創公司
  • 受託研究機構
  • 製藥公司
    • 學名藥
    • 大型製藥企業
    • 中型製藥公司

第11章：醫藥合約研發與生產服務市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：醫藥合約研發與生產服務市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：醫藥合約研發與生產服務市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Aenova Holding GmbH
  • AGC Biologics Inc
  • Alcami Corporation
  • Asymchem Laboratories（Tianjin）Co Ltd
  • Boehringer Ingelheim GmbH
  • Cambrex Corporation
  • Catalent, Inc.
  • Divi's Laboratories Limited
  • Eurofins Scientific SE
  • Evonik Industries AG
  • FAMAR Health Care Services AG
  • Hovione LLC
  • Lonza Group AG
  • Metrics Contract Services LLC
  • Neuland Laboratories Limited
  • Piramal Pharma Ltd
  • Porton Pharma Solutions Limited
  • Recipharm AB
  • Samsung Biologics Co., Ltd.
  • Siegfried Holding AG
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.

第16章 主要專家

Product Code: MRR-9C4233EE7D75

The Pharmaceutical Customized R&D & Production Services Market is projected to grow by USD 111.84 billion at a CAGR of 7.11% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 69.12 billion
Estimated Year [2026] USD 73.05 billion
Forecast Year [2032] USD 111.84 billion
CAGR (%) 7.11%

Pharmaceutical Customized R&D and Production Services: Executive Summary

Pharmaceutical customized R&D and production services support drug developers with outsourced research, development, analytical, clinical, regulatory, manufacturing, and supply-chain capabilities. Demand is shaped by increasingly specialized modalities, tighter quality expectations, shorter development timelines, and the need for flexible capacity across discovery, clinical development, and commercial supply. The market encompasses service models that help sponsors access technical expertise and infrastructure without building every capability internally.

Specialization, Flexibility, and Compliance Are Reshaping Service Delivery

The landscape is shifting toward integrated and modular outsourcing models. Sponsors increasingly seek partners able to coordinate process development, analytical testing, clinical-material production, technology transfer, and regulatory documentation while preserving flexibility to select distinct specialists for complex tasks. At the same time, advanced therapies, highly potent compounds, sterile products, and personalized medicines are raising requirements for containment, validation, cold-chain management, data integrity, and quality-by-design practices. Resilient sourcing is also becoming more important as organizations diversify suppliers, qualify backup capacity, and improve visibility across critical materials and production steps.

Artificial Intelligence Is Improving Discovery, Development, and Manufacturing Workflows

Artificial intelligence is influencing customized services through compound design, target identification, experimental planning, process optimization, deviation analysis, demand planning, and document review. Its practical value depends on validated data, reproducible workflows, human oversight, and clear controls for model governance and intellectual property. Service providers that combine AI with laboratory automation, digital quality systems, and secure data platforms can improve decision support and operational responsiveness, but regulated use requires traceability, cybersecurity, validation, and appropriate review of model outputs rather than unverified automation.

Regional Dynamics Reflect Distinct Capabilities, Regulation, and Supply-Chain Priorities

North America combines deep biotechnology activity, sophisticated clinical infrastructure, and strong demand for specialized development and manufacturing support. Europe emphasizes quality systems, regulatory alignment, advanced therapy expertise, and cross-border coordination. Asia-Pacific offers expanding technical capacity, manufacturing depth, and growing innovation ecosystems, while sponsors continue to assess quality consistency and supply-chain resilience. Latin America is developing regional capabilities with emphasis on access, localization, and partnerships. The Middle East is investing in life-science infrastructure and diversification, and Africa presents opportunities linked to local manufacturing, clinical research, public-health priorities, and capability building.

International Groupings Influence Collaboration, Regulation, and Resilience

ASEAN is relevant to regional manufacturing networks, cross-border supply chains, and the harmonization of technical and regulatory practices. BRICS economies contribute substantial scientific, manufacturing, and patient-population capabilities while navigating differences in regulatory systems and market access. The European Union supports coordinated standards and cross-border development within a mature regulatory framework. G7 members remain influential in advanced research, quality expectations, and high-complexity production. GCC countries are strengthening pharmaceutical and biotechnology infrastructure through investment and diversification initiatives. NATO members have heightened attention to continuity planning, cybersecurity, critical inputs, and secure supply chains, considerations that also affect outsourced pharmaceutical operations.

Country-Level Capabilities Range from Innovation Leadership to Capacity Building

The United States combines extensive biotechnology, clinical research, regulatory, and specialized manufacturing capabilities. Canada contributes strengths in research, clinical development, and cross-border supply networks. Brazil and Mexico support Latin American development and production ecosystems, with opportunities shaped by regulatory coordination and local access priorities. The United Kingdom, Germany, France, Italy, and Spain offer established research, manufacturing, and quality infrastructures within interconnected European systems. China and India provide broad scientific, analytical, and production capabilities, while Japan and South Korea are notable for advanced manufacturing, precision technologies, and quality-focused development. Australia contributes research, clinical, and specialized production expertise. Russia retains scientific and manufacturing capabilities, although collaboration conditions, compliance requirements, and supply-chain access vary by program and jurisdiction.

Industry Leaders Should Build Resilient, Data-Enabled Partnership Models

Leaders should segment outsourcing needs by modality, development stage, risk, and required technical controls before selecting partners. They should qualify providers against scientific depth, quality performance, inspection readiness, cybersecurity, data integrity, business continuity, and technology-transfer capability rather than relying on capacity alone. Dual sourcing or strategically qualified backup options can reduce disruption risk for critical materials and processes. Executives should also establish clear ownership of intellectual property, data, deviations, change controls, and regulatory submissions. Finally, organizations should adopt AI selectively through validated use cases, governed data practices, measurable performance indicators, and continuous human review.

Methodology: Evidence-Based Synthesis of Service, Technology, and Geographic Signals

This executive summary uses the defined pharmaceutical customized R&D and production services scope and organizes findings across service evolution, technology adoption, regional conditions, international groupings, and country-level capabilities. Insights are synthesized from established industry structures, regulatory considerations, operating models, and observable developments in pharmaceutical research and manufacturing. The analysis intentionally excludes market estimates, market shares, forecasts, and company-specific rankings. Geographic interpretations reflect differences in infrastructure, scientific capacity, policy, quality systems, supply-chain priorities, and localization requirements.

Strategic Outlook: Integrated Expertise and Operational Trust Will Define Advantage

Pharmaceutical customized R&D and production services are becoming more specialized, interconnected, and data dependent. Competitive differentiation will increasingly come from the ability to combine scientific expertise, compliant execution, flexible capacity, secure information management, and resilient supply networks. Sponsors and service providers that treat quality, transparency, technology governance, and partnership design as strategic capabilities will be better positioned to manage complex pipelines and changing regulatory expectations across regions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Pharmaceutical Customized R&D & Production Services Market, by Service Category

  • 7.1. Introduction
  • 7.2. Integrated Development Services
    • 7.2.1. Dmpk
    • 7.2.2. Regulatory Affairs
    • 7.2.3. Toxicology
  • 7.3. Manufacturing Services
    • 7.3.1. Api Manufacturing
    • 7.3.2. Fill Finish Manufacturing
    • 7.3.3. Formulation Manufacturing
  • 7.4. Research And Development Services
    • 7.4.1. Clinical Development
    • 7.4.2. Drug Discovery
    • 7.4.3. Preclinical Development

8. Pharmaceutical Customized R&D & Production Services Market, by Molecule Category

  • 8.1. Introduction
  • 8.2. Biologics
    • 8.2.1. Monoclonal Antibody
    • 8.2.2. Recombinant Protein
    • 8.2.3. Vaccines
  • 8.3. Gene Therapy
    • 8.3.1. Nonviral Vector
    • 8.3.2. Viral Vector
  • 8.4. Peptides And Oligonucleotides
    • 8.4.1. Oligonucleotide Therapeutics
    • 8.4.2. Synthetic Peptide
  • 8.5. Small Molecule

9. Pharmaceutical Customized R&D & Production Services Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiovascular
    • 9.2.1. Hypertension
    • 9.2.2. Stroke
  • 9.3. Central Nervous System
    • 9.3.1. Alzheimer Disease
    • 9.3.2. Parkinson Disease
  • 9.4. Infectious Disease
    • 9.4.1. Bacterial Infection
    • 9.4.2. Viral Infection
  • 9.5. Oncology
    • 9.5.1. Hematological Malignancy
    • 9.5.2. Solid Tumor

10. Pharmaceutical Customized R&D & Production Services Market, by Customer Category

  • 10.1. Introduction
  • 10.2. Academic Institutions
  • 10.3. Biotechnology Companies
    • 10.3.1. Established Biotech
    • 10.3.2. Startups
  • 10.4. Contract Research Organizations
  • 10.5. Pharmaceutical Companies
    • 10.5.1. Generic Pharma
    • 10.5.2. Large Pharma
    • 10.5.3. Mid Sized Pharma

11. Pharmaceutical Customized R&D & Production Services Market, by Region

  • 11.1. Introduction
  • 11.2. Asia-Pacific
  • 11.3. North America
  • 11.4. Latin America
  • 11.5. Europe
  • 11.6. Middle East
  • 11.7. Africa

12. Pharmaceutical Customized R&D & Production Services Market, by Group

  • 12.1. Introduction
  • 12.2. ASEAN
  • 12.3. GCC
  • 12.4. European Union
  • 12.5. BRICS
  • 12.6. G7
  • 12.7. NATO

13. Pharmaceutical Customized R&D & Production Services Market, by Country

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. United Kingdom
  • 13.7. Germany
  • 13.8. France
  • 13.9. Russia
  • 13.10. Italy
  • 13.11. Spain
  • 13.12. China
  • 13.13. India
  • 13.14. Japan
  • 13.15. Australia
  • 13.16. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. Market Concentration Analysis, 2025
    • 14.2.1. Concentration Ratio (CR)
    • 14.2.2. Herfindahl Hirschman Index (HHI)
  • 14.3. Recent Developments & Impact Analysis, 2025
  • 14.4. Product Portfolio Analysis, 2025
  • 14.5. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Aenova Holding GmbH
  • 15.2. AGC Biologics Inc
  • 15.3. Alcami Corporation
  • 15.4. Asymchem Laboratories (Tianjin) Co Ltd
  • 15.5. Boehringer Ingelheim GmbH
  • 15.6. Cambrex Corporation
  • 15.7. Catalent, Inc.
  • 15.8. Divi's Laboratories Limited
  • 15.9. Eurofins Scientific SE
  • 15.10. Evonik Industries AG
  • 15.11. FAMAR Health Care Services AG
  • 15.12. Hovione LLC
  • 15.13. Lonza Group AG
  • 15.14. Metrics Contract Services LLC
  • 15.15. Neuland Laboratories Limited
  • 15.16. Piramal Pharma Ltd
  • 15.17. Porton Pharma Solutions Limited
  • 15.18. Recipharm AB
  • 15.19. Samsung Biologics Co., Ltd.
  • 15.20. Siegfried Holding AG
  • 15.21. Syngene International Limited
  • 15.22. Thermo Fisher Scientific Inc.
  • 15.23. WuXi AppTec Co., Ltd.

16. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Pharmaceutical Customized R&D & Production Services Market, Years Considered for the Study
  • FIGURE 2. Global Pharmaceutical Customized R&D & Production Services Market, Research Design
  • FIGURE 3. Global Pharmaceutical Customized R&D & Production Services Market, Research Framework
  • FIGURE 4. Global Pharmaceutical Customized R&D & Production Services Market, Data Triangulation
  • FIGURE 5. Global Pharmaceutical Customized R&D & Production Services Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2025 vs 2032 (%)
  • FIGURE 7. Global Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2025 vs 2032 (%)
  • FIGURE 9. Global Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2025 vs 2032 (%)
  • FIGURE 11. Global Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2025 vs 2032 (%)
  • FIGURE 13. Global Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Pharmaceutical Customized R&D & Production Services Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 15. Global Pharmaceutical Customized R&D & Production Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Pharmaceutical Customized R&D & Production Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 17. Global Pharmaceutical Customized R&D & Production Services Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 18. Global Pharmaceutical Customized R&D & Production Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 19. Global Pharmaceutical Customized R&D & Production Services Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Pharmaceutical Customized R&D & Production Services Market Segmentation & Coverage
  • TABLE 2. Global Pharmaceutical Customized R&D & Production Services Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2017-2032 (USD Million)
  • TABLE 4. Global Integrated Development Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Integrated Development Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Integrated Development Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Dmpk Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Dmpk Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Dmpk Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Regulatory Affairs Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 11. Global Regulatory Affairs Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 12. Global Regulatory Affairs Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 13. Global Toxicology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 14. Global Toxicology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 15. Global Toxicology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 16. Global Manufacturing Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 17. Global Manufacturing Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 18. Global Manufacturing Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 19. Global Api Manufacturing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 20. Global Api Manufacturing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 21. Global Api Manufacturing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 22. Global Fill Finish Manufacturing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 23. Global Fill Finish Manufacturing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 24. Global Fill Finish Manufacturing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 25. Global Formulation Manufacturing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 26. Global Formulation Manufacturing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 27. Global Formulation Manufacturing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 28. Global Research And Development Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 29. Global Research And Development Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 30. Global Research And Development Services Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 31. Global Clinical Development Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 32. Global Clinical Development Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 33. Global Clinical Development Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 34. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Preclinical Development Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Preclinical Development Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Preclinical Development Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2017-2032 (USD Million)
  • TABLE 41. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 42. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 43. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 44. Global Monoclonal Antibody Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 45. Global Monoclonal Antibody Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 46. Global Monoclonal Antibody Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 47. Global Recombinant Protein Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 48. Global Recombinant Protein Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 49. Global Recombinant Protein Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 50. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 51. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 52. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 53. Global Gene Therapy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Gene Therapy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Gene Therapy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Nonviral Vector Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Nonviral Vector Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Nonviral Vector Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Viral Vector Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Viral Vector Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Viral Vector Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Peptides And Oligonucleotides Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Peptides And Oligonucleotides Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Peptides And Oligonucleotides Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Oligonucleotide Therapeutics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Oligonucleotide Therapeutics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Oligonucleotide Therapeutics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Synthetic Peptide Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Synthetic Peptide Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Synthetic Peptide Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Small Molecule Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 72. Global Small Molecule Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 73. Global Small Molecule Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 74. Global Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 75. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Hypertension Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Global Hypertension Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 80. Global Hypertension Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 81. Global Stroke Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Global Stroke Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. Global Stroke Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 84. Global Central Nervous System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Global Central Nervous System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 86. Global Central Nervous System Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 87. Global Alzheimer Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 88. Global Alzheimer Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 89. Global Alzheimer Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 90. Global Parkinson Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 91. Global Parkinson Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 92. Global Parkinson Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 93. Global Infectious Disease Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 94. Global Infectious Disease Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 95. Global Infectious Disease Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 96. Global Bacterial Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 97. Global Bacterial Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 98. Global Bacterial Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 99. Global Viral Infection Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 100. Global Viral Infection Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 101. Global Viral Infection Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 102. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 103. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 104. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 105. Global Hematological Malignancy Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 106. Global Hematological Malignancy Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 107. Global Hematological Malignancy Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 108. Global Solid Tumor Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Global Solid Tumor Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 110. Global Solid Tumor Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 111. Global Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2017-2032 (USD Million)
  • TABLE 112. Global Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 113. Global Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 114. Global Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 115. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 116. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 117. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 118. Global Established Biotech Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 119. Global Established Biotech Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 120. Global Established Biotech Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 121. Global Startups Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 122. Global Startups Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 123. Global Startups Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 124. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 125. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 126. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 127. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 128. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 129. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 130. Global Generic Pharma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 131. Global Generic Pharma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 132. Global Generic Pharma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 133. Global Large Pharma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 134. Global Large Pharma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 135. Global Large Pharma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 136. Global Mid Sized Pharma Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 137. Global Mid Sized Pharma Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 138. Global Mid Sized Pharma Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 139. Global Pharmaceutical Customized R&D & Production Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 140. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 141. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2017-2032 (USD Million)
  • TABLE 142. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Integrated Development Services, 2017-2032 (USD Million)
  • TABLE 143. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
  • TABLE 144. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Research And Development Services, 2017-2032 (USD Million)
  • TABLE 145. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2017-2032 (USD Million)
  • TABLE 146. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 147. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
  • TABLE 148. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Peptides And Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 149. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 150. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 151. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Central Nervous System, 2017-2032 (USD Million)
  • TABLE 152. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 153. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 154. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2017-2032 (USD Million)
  • TABLE 155. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 156. Asia-Pacific Pharmaceutical Customized R&D & Production Services Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 157. North America Pharmaceutical Customized R&D & Production Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 158. North America Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2017-2032 (USD Million)
  • TABLE 159. North America Pharmaceutical Customized R&D & Production Services Market Size, by Integrated Development Services, 2017-2032 (USD Million)
  • TABLE 160. North America Pharmaceutical Customized R&D & Production Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
  • TABLE 161. North America Pharmaceutical Customized R&D & Production Services Market Size, by Research And Development Services, 2017-2032 (USD Million)
  • TABLE 162. North America Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2017-2032 (USD Million)
  • TABLE 163. North America Pharmaceutical Customized R&D & Production Services Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 164. North America Pharmaceutical Customized R&D & Production Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
  • TABLE 165. North America Pharmaceutical Customized R&D & Production Services Market Size, by Peptides And Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 166. North America Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 167. North America Pharmaceutical Customized R&D & Production Services Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 168. North America Pharmaceutical Customized R&D & Production Services Market Size, by Central Nervous System, 2017-2032 (USD Million)
  • TABLE 169. North America Pharmaceutical Customized R&D & Production Services Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 170. North America Pharmaceutical Customized R&D & Production Services Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 171. North America Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2017-2032 (USD Million)
  • TABLE 172. North America Pharmaceutical Customized R&D & Production Services Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 173. North America Pharmaceutical Customized R&D & Production Services Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 174. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 175. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2017-2032 (USD Million)
  • TABLE 176. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Integrated Development Services, 2017-2032 (USD Million)
  • TABLE 177. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
  • TABLE 178. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Research And Development Services, 2017-2032 (USD Million)
  • TABLE 179. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2017-2032 (USD Million)
  • TABLE 180. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 181. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
  • TABLE 182. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Peptides And Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 183. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 184. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 185. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Central Nervous System, 2017-2032 (USD Million)
  • TABLE 186. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 187. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 188. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2017-2032 (USD Million)
  • TABLE 189. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 190. Latin America Pharmaceutical Customized R&D & Production Services Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 191. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 192. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2017-2032 (USD Million)
  • TABLE 193. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Integrated Development Services, 2017-2032 (USD Million)
  • TABLE 194. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
  • TABLE 195. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Research And Development Services, 2017-2032 (USD Million)
  • TABLE 196. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2017-2032 (USD Million)
  • TABLE 197. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 198. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
  • TABLE 199. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Peptides And Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 200. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 201. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 202. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Central Nervous System, 2017-2032 (USD Million)
  • TABLE 203. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 204. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 205. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2017-2032 (USD Million)
  • TABLE 206. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 207. Europe Pharmaceutical Customized R&D & Production Services Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 208. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 209. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2017-2032 (USD Million)
  • TABLE 210. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Integrated Development Services, 2017-2032 (USD Million)
  • TABLE 211. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
  • TABLE 212. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Research And Development Services, 2017-2032 (USD Million)
  • TABLE 213. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2017-2032 (USD Million)
  • TABLE 214. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 215. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
  • TABLE 216. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Peptides And Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 217. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 218. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 219. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Central Nervous System, 2017-2032 (USD Million)
  • TABLE 220. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 221. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 222. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2017-2032 (USD Million)
  • TABLE 223. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 224. Middle East Pharmaceutical Customized R&D & Production Services Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 225. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 226. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2017-2032 (USD Million)
  • TABLE 227. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Integrated Development Services, 2017-2032 (USD Million)
  • TABLE 228. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
  • TABLE 229. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Research And Development Services, 2017-2032 (USD Million)
  • TABLE 230. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2017-2032 (USD Million)
  • TABLE 231. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 232. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
  • TABLE 233. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Peptides And Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 234. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 235. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 236. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Central Nervous System, 2017-2032 (USD Million)
  • TABLE 237. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 238. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 239. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2017-2032 (USD Million)
  • TABLE 240. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 241. Africa Pharmaceutical Customized R&D & Production Services Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 242. Global Pharmaceutical Customized R&D & Production Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 243. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 244. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2017-2032 (USD Million)
  • TABLE 245. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Integrated Development Services, 2017-2032 (USD Million)
  • TABLE 246. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
  • TABLE 247. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Research And Development Services, 2017-2032 (USD Million)
  • TABLE 248. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2017-2032 (USD Million)
  • TABLE 249. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 250. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
  • TABLE 251. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Peptides And Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 252. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 253. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 254. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Central Nervous System, 2017-2032 (USD Million)
  • TABLE 255. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 256. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 257. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2017-2032 (USD Million)
  • TABLE 258. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 259. ASEAN Pharmaceutical Customized R&D & Production Services Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 260. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 261. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2017-2032 (USD Million)
  • TABLE 262. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Integrated Development Services, 2017-2032 (USD Million)
  • TABLE 263. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
  • TABLE 264. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Research And Development Services, 2017-2032 (USD Million)
  • TABLE 265. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2017-2032 (USD Million)
  • TABLE 266. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 267. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
  • TABLE 268. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Peptides And Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 269. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 270. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 271. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Central Nervous System, 2017-2032 (USD Million)
  • TABLE 272. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 273. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 274. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2017-2032 (USD Million)
  • TABLE 275. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 276. GCC Pharmaceutical Customized R&D & Production Services Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 277. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 278. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2017-2032 (USD Million)
  • TABLE 279. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Integrated Development Services, 2017-2032 (USD Million)
  • TABLE 280. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Manufacturing Services, 2017-2032 (USD Million)
  • TABLE 281. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Research And Development Services, 2017-2032 (USD Million)
  • TABLE 282. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Molecule Category, 2017-2032 (USD Million)
  • TABLE 283. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Biologics, 2017-2032 (USD Million)
  • TABLE 284. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Gene Therapy, 2017-2032 (USD Million)
  • TABLE 285. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Peptides And Oligonucleotides, 2017-2032 (USD Million)
  • TABLE 286. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Therapeutic Area, 2017-2032 (USD Million)
  • TABLE 287. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Cardiovascular, 2017-2032 (USD Million)
  • TABLE 288. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Central Nervous System, 2017-2032 (USD Million)
  • TABLE 289. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Infectious Disease, 2017-2032 (USD Million)
  • TABLE 290. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Oncology, 2017-2032 (USD Million)
  • TABLE 291. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Customer Category, 2017-2032 (USD Million)
  • TABLE 292. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Biotechnology Companies, 2017-2032 (USD Million)
  • TABLE 293. European Union Pharmaceutical Customized R&D & Production Services Market Size, by Pharmaceutical Companies, 2017-2032 (USD Million)
  • TABLE 294. BRICS Pharmaceutical Customized R&D & Production Services Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 295. BRICS Pharmaceutical Customized R&D & Production Services Market Size, by Service Category, 2017-2032 (USD Million)
  • TABLE 296. BRICS Pharmace